Nektar Therapeutics (NKTR) Gross Profit: 2010-2025
Historic Gross Profit for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to $1.5 million.
- Nektar Therapeutics' Gross Profit fell 88.61% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year decrease of 67.20%. This contributed to the annual value of $56.4 million for FY2024, which is 6.23% up from last year.
- Nektar Therapeutics' Gross Profit amounted to $1.5 million in Q3 2025, which was up 75.44% from $851,000 recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' Gross Profit registered a high of $20.7 million during Q2 2021, and its lowest value of -$6.8 million during Q1 2025.
- In the last 3 years, Nektar Therapeutics' Gross Profit had a median value of $12.3 million in 2024 and averaged $9.5 million.
- As far as peak fluctuations go, Nektar Therapeutics' Gross Profit surged by 54.41% in 2024, and later crashed by 165.17% in 2025.
- Quarterly analysis of 5 years shows Nektar Therapeutics' Gross Profit stood at $18.8 million in 2021, then dropped by 16.22% to $15.8 million in 2022, then decreased by 15.63% to $13.3 million in 2023, then spiked by 54.41% to $20.6 million in 2024, then tumbled by 88.61% to $1.5 million in 2025.
- Its last three reported values are $1.5 million in Q3 2025, $851,000 for Q2 2025, and -$6.8 million during Q1 2025.